Crispr Therapeutics shares owned by Boothbay Fund Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Boothbay Fund Management
from 13F filings
Historical chart of Boothbay Fund Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Boothbay Fund Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $2.3M | 51k | 45.39 |
| 2023-06-30 | $4.6M | 82k | 56.14 |
| 2021-09-30 | $2.6M | 23k | 111.91 |
| 2021-06-30 | $5.9M | 36k | 161.87 |
| 2021-03-31 | $216k | 1.8k | 122.03 |
| 2019-06-30 | $1.1M | 23k | 47.11 |